Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In a study (Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery, 22 May 2021), AL Lewis, N McEntee, J Holland, A Patel, this included ten Phase 3 clinical trials that demonstrated the tablet formulation to be as effective as the already approved injectable form of the drug, and more effective than competitor products in terms of its blood glucose lowering effects and weight loss. Manufacturer Information The brand name Rybelsus is manufactured by Novo Nordisk in Canada, India, and the United Kingdom
Semaglutide Pricing Prices reflect a 2 mL vial, typically about a one-month supply depending on your prescribed dose
Formulated for once-weekly administration via a specialized pre-filled pen to ensure consistent dosing and patient compliance
Commonly Reported Side Effects The most frequently observed adverse events in the Phase 2 trial were gastrointestinal in nature, including nausea, vomiting, diarrhea, and constipation
US$ 29.61
US$ 25.15
US$ 22.77
US$ 20.72
US$ 22.43
US$ 28.35
